PROPAN: Bayesian dose-finding of propranolol combined with metronomic fixed-dose cyclophosphamide based on bivariate efficacy-tolerability outcomes in patients with locally advanced or metastatic angiosarcoma (LAMA): A phase I-II sequential trial by the French Sarcoma Group.

Authors: Sebastien Salas, Christine Chevreau, Elisabeth Jouve, Nicolas Penel, Axel Le Cesne, Emmanuelle Bompas, Francois Bertucci, Jean Emmanuel Kurtz, Nicolas Isambert, Loic Chaigneau, Joelle Micallef, Eva Foinet, Nicolas Andre, Sarah Zohar, Jean-Yves Blay

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e23542

Source: Full article

---

Abstract

e23542